In 2017, the FDA launched its Digital Health Action Plan with legislation specifically targeting digital health, in which it intends to harness the potential of digital health in a conscientious manner. In this second session, our guest experts will present an overview of the regulatory landscape and the challenges related to privacy and data protection. They will also address the future of reimbursement for digital health products.
The Center for Technology Licensing at Cornell University through its Weill office manages WCM technologies and serves researchers with the commercialization of their IP.
Register to receive the Zoom details
Wednesday, April 7, 2021 at 12:00pm to 1:00pmVirtual Event